Literature DB >> 8220228

Clinical applications of flow cytometry in hematology and immunology.

M Drouet1, O Lees.   

Abstract

Rapid developments in computer technology combined with new fluorescent dyes and monoclonal antibody production have led to the development of a powerful tool: flow cytometry. The techniques of flow cytometry can be applied in a wide clinical field, from routine tasks to research in immunology and hematology. The availability of automated instruments and standardized sample preparation methods have led to its daily clinical use, helping diagnosis, prognosis or monitoring therapy. Further advances will be made with the introduction of multi-parametric analysis ie quantification of antigen expression of cell surface antigens.

Mesh:

Substances:

Year:  1993        PMID: 8220228     DOI: 10.1016/0248-4900(93)90117-w

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  3 in total

1.  Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometry.

Authors:  Cassandra Balinas; Helene Cabanas; Donald Staines; Sonya Marshall-Gradisnik
Journal:  BMC Immunol       Date:  2019-05-10       Impact factor: 3.615

2.  Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist.

Authors:  Timothy Wyant; Alan Lackey; Marie Green
Journal:  J Transl Med       Date:  2008-12-01       Impact factor: 5.531

3.  Earth Mover's Distance (EMD): A True Metric for Comparing Biomarker Expression Levels in Cell Populations.

Authors:  Darya Y Orlova; Noah Zimmerman; Stephen Meehan; Connor Meehan; Jeffrey Waters; Eliver E B Ghosn; Alexander Filatenkov; Gleb A Kolyagin; Yael Gernez; Shanel Tsuda; Wayne Moore; Richard B Moss; Leonore A Herzenberg; Guenther Walther
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.